KLRK1 and brain ischemia: OGD treatment mimics the hypoxia and glucose-deprived environment that occurs during cerebral ischemia, which may affect the expression of NKG2D on NK cells, indicating that hypoxia and glucose deprivation regulate NKG2D expression.